Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$2.45 USD
-0.10 (-3.92%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.45 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/7/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.07 |
Last EPS Surprise | 53.33% |
ABR | 1.25 |
Earnings ESP
|
-17.39% |
---|---|
Current Year | -0.24 |
Next Year | -0.08 |
EPS (TTM) | -0.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 32.50M | 33.67M | 142.73M | 173.43M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 33.50M | 35.00M | 148.50M | 175.00M |
Low Estimate | 30.90M | 32.30M | 138.00M | 171.20M |
Year ago Sales | 29.62M | 31.76M | 127.04M | 142.73M |
Year over Year Growth Est. | 9.72% | 6.00% | 12.35% | 21.51% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.06 | -0.24 | -0.08 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.09 | -0.07 | -0.28 | -0.06 |
High Estimate | -0.03 | -0.03 | -0.09 | -0.02 |
Low Estimate | -0.11 | -0.09 | -0.35 | -0.15 |
Year ago EPS | -0.27 | -0.35 | -0.80 | -0.24 |
Year over Year Growth Est. | 70.37% | 82.86% | 70.00% | 68.06% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.06 | -0.24 | -0.08 |
7 Days Ago | -0.07 | -0.06 | -0.22 | -0.09 |
30 Days Ago | -0.07 | -0.06 | -0.22 | -0.09 |
60 Days Ago | -0.11 | -0.09 | -0.48 | -0.26 |
90 Days Ago | -0.11 | -0.09 | -0.38 | -0.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.07 | -0.28 | -0.06 |
Zacks Consensus Estimate | -0.08 | -0.06 | -0.24 | -0.08 |
Earnings ESP | -17.39% | -10.53% | -16.67% | 21.74% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.07 | -0.17 | -0.35 | -0.27 | NA |
Estimate | -0.15 | -0.31 | -0.23 | -0.17 | NA |
Difference | 0.08 | 0.14 | -0.12 | -0.10 | 0.00 |
Surprise | 53.33% | 45.16% | -52.17% | -58.82% | -3.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more